North America Human Milk Oligosaccharides Market is estimated at USD xx. xx million in 2021 and is predicted to range an over of USD xx. xx million in the foreseen period. The North America Human Milk Oligosaccharides Market is predictable to knowledge reasonable growth to record a CAGR of xx.xx% through the estimated period (2022 - 2027).
Human milk oligosaccharides (HMOs) are primarily found in human milk since these are complex bioactive sugar molecules. It works as growth substrates for certain beneficial bacteria. As human milk oligosaccharides (HMOs) are advantageous to the microbiome and immunity, the critical player seeks and develops many new techniques, in particular the extraction of HMO from cow's milk, the practice of expensive techniques (chemical synthesis or enzymatic), or the use of microbes to produce them. Human Milk Oligosaccharide (HMO) products are expensive because a large amount of human milk must be synthesized to make a handful of HMOs. Therefore, as a remedy, extraction and synthesis techniques are improved.
Recent Developments
In May 2019, Glycosyn and BASF contracted a partnership agreement to grow and commercial human milk oligosaccharides (HMOs) for extensive use in medical foods, functional nutrition, and nutritional additions. Moreover, as part of the acquisition, BASF will further establish more of its most abundant PREBILACTM HMO offering, the PREBILACTM 2'-fucosyllactose (2'-FL) brand, to a massive number of population.
Market Drivers and Restraints:
The human milk oligosaccharide (HMO) market is expected to witness reversal during the forecast period; Key factors driving market growth include an ever-expanding reach in infant formulas and functional beverages, rapid technological advancements in the product line, increased health awareness, and the rise of the dairy industry. In addition, changes in lifestyles focused on nutritious foods are likely to increase the need for products. Among all the applications, the use in infant formulas registers significant participation in terms of volume for this market; this is due to concerns about malnutrition and infant mortality around the world. Human Milk Oligosaccharides (HMO) respect the prebiotic properties, the ability to improve memory and brain development, and its high nutritional content; these qualities drive the market demand for Human Milk Oligosaccharides (HMO). Furthermore, adding HMO to functional food and drink products promotes the growth of good bacteria and can also kill harmful bacteria like salmonella and campylobacter. Although the demand and need for breast milk oligosaccharides (HMO) in the market can be seen in a generalized way, many manufacturers like Inbiose and others use methods like fermentation technologies, chemical and enzymatic synthesis, etc., for the manufacture of oligosaccharides from breastmilk. . Among the methods mentioned above, chemical and enzymatic synthesis methods are expensive and have low availability of raw material, which restricts the market.
Market Segmentation:
Product:
Based on the product, the Lacto-n-tetraose tends to dominate the market since it simultaneously increased and decreased the growth of beneficial bifidobacteria and pathogenic bacteria. These customers are believed to be driving the development of the human milk oligosaccharides (HMO) market. It can also be ascribed to the fact that it positively affects the nervous system and cognition and reduces the risk of inflammation in the baby.
Application:
The application of infant formula was the most prominent in 2019. Additionally, the demand for human milk oligosaccharides (HMOs) in infant formula is increasing by supporting the development of digestion, immunity, and cognition, which are known to promote the growth of the human milk oligosaccharides (HMOs) market.
Impact of covid-19 on North America Human Milk Oligosaccharides Market
The COVID-19 pandemic has had a significant effect on the market for human milk oligosaccharides (HMOs). HMO demand increased during the shutdown due to panic purchases for home consumption during the initial phase of the pandemic. As a result, HMO sales increased during the pandemic as they served as immunity boosters.
Regional Analysis:
Geographically the North America Human Milk Oligosaccharides Market is segmented into US, Canada, Mexico and Rest of North America.
The North America Human Milk Oligosaccharides market has been categorized based on geography to provide a clear understanding of the market. North America Human Milk Oligosaccharides Market has been divided into the United States, Canada, Mexico, and the rest of North America. North America has a substantial industry stake in the market, as many global companies launch new product lines, with HMO as a critical ingredient in the region. Increased customer awareness of the health benefits of HMOs in infant nutrition is one of the key factors aiding the marketplace to grow additional in the country with numerous product presentations. For example, in 2016, Jennewein Biotechnologie GmbH produced 2'-fucosillactose, for the first time as a food grade product to meet the demand of the US infant formula market. Furthermore, with the increase in the inclusion of HMOs in prebiotics already contributing to the development of commensal bacteria and the growing demand for functional foods and beverages and dietary supplements for better health and digestion, the HMO market is expected to grow in the region over the forecast.
Leading Company
Abbott had the largest share of the North America Human Milk Oligosaccharides Market in terms of sales revenue in 2021.
Key Players
The North America Human Milk Oligosaccharides Market is concentrated with well-established players. Key players in the North America Human Milk Oligosaccharides Market include
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region